Geode Capital Management LLC raised its stake in MAXIMUS, Inc. (NYSE:MMS) by 10.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 641,629 shares of the health services provider’s stock after acquiring an additional 61,311 shares during the period. Geode Capital Management LLC owned approximately 0.98% of MAXIMUS worth $45,927,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. American International Group Inc. increased its holdings in MAXIMUS by 0.5% in the 4th quarter. American International Group Inc. now owns 176,692 shares of the health services provider’s stock valued at $12,648,000 after acquiring an additional 907 shares during the last quarter. Pacer Advisors Inc. increased its holdings in MAXIMUS by 11.5% in the 3rd quarter. Pacer Advisors Inc. now owns 9,688 shares of the health services provider’s stock valued at $625,000 after acquiring an additional 1,000 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. increased its holdings in MAXIMUS by 6.6% in the 3rd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 18,042 shares of the health services provider’s stock valued at $1,164,000 after acquiring an additional 1,110 shares during the last quarter. Commonwealth Equity Services Inc increased its holdings in MAXIMUS by 27.2% in the 3rd quarter. Commonwealth Equity Services Inc now owns 5,235 shares of the health services provider’s stock valued at $337,000 after acquiring an additional 1,120 shares during the last quarter. Finally, Cubist Systematic Strategies LLC increased its holdings in MAXIMUS by 28.5% in the 3rd quarter. Cubist Systematic Strategies LLC now owns 5,100 shares of the health services provider’s stock valued at $329,000 after acquiring an additional 1,131 shares during the last quarter. Institutional investors own 96.72% of the company’s stock.
A number of analysts have issued reports on the stock. Canaccord Genuity reiterated a “buy” rating on shares of MAXIMUS in a report on Wednesday, December 27th. Zacks Investment Research upgraded shares of MAXIMUS from a “sell” rating to a “hold” rating in a report on Wednesday, January 17th. Finally, Maxim Group restated a “hold” rating and issued a $69.00 target price (up from $66.00) on shares of MAXIMUS in a report on Thursday, February 8th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $66.60.
In related news, Director Russell A. Beliveau sold 1,000 shares of the company’s stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $71.73, for a total transaction of $71,730.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, General Counsel David Francis sold 3,600 shares of the company’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $64.50, for a total transaction of $232,200.00. Following the transaction, the general counsel now owns 10,017 shares in the company, valued at $646,096.50. The disclosure for this sale can be found here. Insiders have sold a total of 44,600 shares of company stock worth $3,014,830 over the last quarter. 3.10% of the stock is currently owned by insiders.
Shares of MAXIMUS, Inc. (MMS) opened at $68.11 on Friday. MAXIMUS, Inc. has a fifty-two week low of $57.12 and a fifty-two week high of $72.71. The company has a quick ratio of 2.57, a current ratio of 2.57 and a debt-to-equity ratio of 0.01. The firm has a market cap of $4,424.75, a PE ratio of 20.27, a PEG ratio of 2.26 and a beta of 1.18.
MAXIMUS (NYSE:MMS) last posted its earnings results on Thursday, February 8th. The health services provider reported $0.78 earnings per share for the quarter, topping analysts’ consensus estimates of $0.77 by $0.01. MAXIMUS had a net margin of 8.99% and a return on equity of 22.93%. The firm had revenue of $623.10 million for the quarter, compared to the consensus estimate of $624.36 million. During the same period in the previous year, the firm posted $0.71 EPS. The business’s quarterly revenue was up 2.6% on a year-over-year basis. research analysts anticipate that MAXIMUS, Inc. will post 3.44 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Wednesday, February 28th. Investors of record on Thursday, February 15th were issued a dividend of $0.045 per share. The ex-dividend date was Wednesday, February 14th. This represents a $0.18 annualized dividend and a yield of 0.26%. MAXIMUS’s payout ratio is 5.36%.
COPYRIGHT VIOLATION NOTICE: “Geode Capital Management LLC Increases Holdings in MAXIMUS, Inc. (MMS)” was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be viewed at https://ledgergazette.com/2018/03/18/geode-capital-management-llc-increases-holdings-in-maximus-inc-mms.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.